3[3]Zubkin M L, Selivanov N A, Stakhanova V M, et al. Distribution and features of infection with HBV and HCV during hemodialysis treatment[J]. Vopr-Virusol, 2000, 45(1): 10-14.
4[4]Hutin Y J, Goldstein S T, Varma J K, et al. An outbreak of hospital-acquired HBV infection among patients receiving chronic hemodialysis[J]. Infec. Control. Hosp. Epidemiol, 1999, 20(11): 731-735.
5[5]Alter M J. HCV infection in the United States[J]. J Hepatol, 1999, 31 (Suppl 1): 88-91.
9[9]Lopez Navedo P J, Lebron R R, Gonzalez T J, et al. Prevalence of HCV infection at three hemodialysis units in the western region of Puerto Rico[J]. Bol.Asoc.Med.P.R.1999, 91(7-12): 100-2.
10[10]Dentico P, Sacco R, Buongiorno R, et al. HCV-RNA immunoglobulin M anti-HCV and risk factors inhemodialysis patients[J]. Microbios, 1999, 99(392): 55-62.
3Centers for Disease Control. Health care workers and laboratory personnel recommendations for prevention of HIV transmission in health care set tings [J]. MMWR， 1987，36:51～69(1～18s).
4Centers for Disease Control. Guidelines for prevention of transmission o f human immunodeficiency virus and hepatitis B virus to health care and public sa fety works [J]. MMWR， 1989，39(s-6).
5Centers for Disease Control. Recommendations for prevention of HIV trans mission in health-care settings [J]. MMWR， 1987，36(2s): 1s～18s.
6Korniewicz DM, Kirwin M, Larson E. Do your gloves fit the task [J]. Am J Nurs， 1991，91:38～40.
7Kaczmarek PG, Moore RM, Mccrohan J， et al. Glove use by health care workers :results of a tristate investigation [J]. Am J Infect Control， 1 991，19:228～232.
8Korniewicz DM. Effectiveness of glove barriers usd in clinical settings [J]. Med surg Nurs， 1992，1:29～32.
9Elizabeth A, Bolyard RN, Tablan OC， et al. Gulideline for infection control in healthcare personnel [J]. Infection Control And Hospital Epid emiology， 1998， 19:410～422.
5CDC. Recommendations for preventing transmission of infections among chronic hemodialysis patients[ s], 2001.
6ERHARDT A, REINEKE U, BONDIN D, et al. Mutations of the core promoter and response to inferferon treatment in chronic replicative hepatitis B[J]. Hepatology, 2000, 31:716-725.
7Hans M G.Hepatitis B virus infection in hemodialysis paitients[J].Semin Nephrol,2002,22(4):340-350.
8Nakatani T, Tsuchida K, Sugimura K, et al. Response of peripheral blood mononuclear cells in hemodialyzed patients against endotoxin and muramyldipeptide[J]. Int J Mol Med, 2002,10(4):469-72.
